During the past decade, Queen Silvia Children's Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Silvia Children's Hospital" #1 sponsor was "PTC Therapeutics" with 5 trials, followed by "ReveraGen BioPharma, Inc." with 4 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored, "Catabasis Pharmaceuticals" with 2 trials sponsored and "Cooperative International Neuromuscular Research Group" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Silvia Children's Hospital" #1 collaborator was "Cooperative International Neuromuscular Research Group" with 4 trials as a collaborator, "University of Pittsburgh" with 4 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Queen Silvia Children's Hospital" are "Duchenne Muscular Dystrophy" (10 trials), "Becker Muscular Dystrophy" (3 trials), "Muscular Dystrophy, Duchenne" (3 trials), "Genetic Diseases, Inborn" (2 trials) and "Genetic Diseases, X-Linked" (2 trials). Many other conditions were trialed in "Queen Silvia Children's Hospital" in a lesser frequency.

Most popular intervention types in "Queen Silvia Children's Hospital" are "Drug" (17 trials), "Biological" (3 trials), "Other" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ataluren" (5 trials), "Placebo" (4 trials), "Edasalonexent" (2 trials), "Vamorolone 0.25 mg/day/day" (2 trials) and "Vamorolone 0.75 mg/day/day" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Silvia Children's Hospital" are 14 trials for "All" genders, 13 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Queen Silvia Children's Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Queen Silvia Children's Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Silvia Children's Hospital, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".